Tuberc Respir Dis.  2013 Dec;75(6):231-235.

Druggable Targets of Squamous Cell Lung Cancer

  • 1Division of Pulmonology, Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea.


Knowledge of molecular pathogenesis of non-small cell lung cancer has increased remarkably and changed the principles of treatment, especially during the past decade. These advancements have been limited mainly to adenocarcinoma of the lung. Recently, genetic alterations in squamous cell lung cancer (SQCLC) have been detailed and positive results of clinical trials using agents targeting these changes have indicated the potential for improved treatment outcomes for SQCLC.


Carcinoma, Squamous Cell; Lung Neoplasms
Full Text Links
  • TRD
  • Twitter
  • Facebook
Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: